` 4595 (Mizuho Medy Co Ltd) vs Nikkei 225 Comparison - Alpha Spread

4595
vs
N
Nikkei 225

Over the past 12 months, Mizuho Medy Co Ltd has underperformed Nikkei 225, delivering a return of 0% compared to the Nikkei 225's +29% growth.

Stocks Performance
4595 vs Nikkei 225

Loading
4595
Nikkei 225
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
4595 vs Nikkei 225

Performance Gap Between 4595 and N225
HIDDEN
Show

Performance By Year
4595 vs Nikkei 225

Loading
4595
Nikkei 225
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Mizuho Medy Co Ltd vs Peers

Nikkei 225
4595
ABT
ISRG
BSX
SYK
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Mizuho Medy Co Ltd
Glance View

Market Cap
34.4B JPY
Industry
Health Care

Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.

Mizuho Medy Co Ltd Intrinsic Value
HIDDEN
Show
Back to Top